These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 12702531)
1. Pharmacokinetic study of patients with follicular or mantle cell lymphoma treated with rituximab as 'in vivo purge' and consolidative immunotherapy following autologous stem cell transplantation. Mangel J; Buckstein R; Imrie K; Spaner D; Franssen E; Pavlin P; Boudreau A; Pennell N; Combs D; Berinstein NL Ann Oncol; 2003 May; 14(5):758-65. PubMed ID: 12702531 [TBL] [Abstract][Full Text] [Related]
2. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma. Mangel J; Buckstein R; Imrie K; Spaner D; Crump M; Tompkins K; Reis M; Perez-Ordonez B; Deodhare S; Romans R; Pennell N; Robinson JB; Hewitt K; Richardson P; Lima A; Pavlin P; Berinstein NL Semin Oncol; 2002 Feb; 29(1 Suppl 2):56-69. PubMed ID: 11842390 [TBL] [Abstract][Full Text] [Related]
3. Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation. Pettengell R; Schmitz N; Gisselbrecht C; Smith G; Patton WN; Metzner B; Caballero D; Tilly H; Walewski JA; Bence-Bruckler I; To B; Geisler CH; Schots R; Kimby E; Taverna CJ; Kozák T; Dreger P; Uddin R; Ruiz de Elvira C; Goldstone AH J Clin Oncol; 2013 May; 31(13):1624-30. PubMed ID: 23547078 [TBL] [Abstract][Full Text] [Related]
4. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma. Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026 [TBL] [Abstract][Full Text] [Related]
5. Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study. Belhadj K; Delfau-Larue MH; Elgnaoui T; Beaujean F; Beaumont JL; Pautas C; Gaillard I; Kirova Y; Allain A; Gaulard P; Farcet JP; Reyes F; Haioun C Ann Oncol; 2004 Mar; 15(3):504-10. PubMed ID: 14998857 [TBL] [Abstract][Full Text] [Related]
7. A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma. Lazzarino M; Arcaini L; Bernasconi P; Alessandrino EP; Gargantini L; Cairoli R; Orlandi E; Astori C; Brusamolino E; Pagnucco G; Colombo AA; Calatroni S; Iacona I; Regazzi MB; Morra E Br J Haematol; 2002 Jan; 116(1):229-35. PubMed ID: 11841421 [TBL] [Abstract][Full Text] [Related]
8. Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study. Brugger W; Hirsch J; Grünebach F; Repp R; Brossart P; Vogel W; Kopp HG; Manz MG; Bitzer M; Schlimok G; Kaufmann M; Ganser A; Fehnle K; Gramatzki M; Kanz L Ann Oncol; 2004 Nov; 15(11):1691-8. PubMed ID: 15520073 [TBL] [Abstract][Full Text] [Related]
9. Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion. Magni M; Di Nicola M; Devizzi L; Matteucci P; Lombardi F; Gandola L; Ravagnani F; Giardini R; Dastoli G; Tarella C; Pileri A; Bonadonna G; Gianni AM Blood; 2000 Aug; 96(3):864-9. PubMed ID: 10910898 [TBL] [Abstract][Full Text] [Related]
11. Rituximab: enhancing stem cell transplantation in mantle cell lymphoma. Gianni AM; Cortelazzo S; Magni M; Martelli M; Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S10-3. PubMed ID: 11840155 [TBL] [Abstract][Full Text] [Related]
12. Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma. Pettengell R Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S1-4. PubMed ID: 11840153 [TBL] [Abstract][Full Text] [Related]
13. Rituximab: enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphoma. Gisselbrecht C; Mounier N Semin Oncol; 2003 Feb; 30(1 Suppl 2):28-33. PubMed ID: 12652462 [TBL] [Abstract][Full Text] [Related]
14. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma. Arcaini L; Orlandi E; Alessandrino EP; Iacona I; Brusamolino E; Bonfichi M; Bernasconi P; Calatroni S; Tenore A; Montanari F; Troletti D; Pascutto C; Regazzi M; Lazzarino M Bone Marrow Transplant; 2004 Jul; 34(2):175-9. PubMed ID: 15170171 [TBL] [Abstract][Full Text] [Related]
15. Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma. Berinstein NL; Buckstein R; Imrie K; Spaner D; Mangel J; Tompkins K; Pennell N; Reis M; Pavlin P; Lima A; Couvadia A; Robinson J; Richardson P Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S14-7. PubMed ID: 11840156 [TBL] [Abstract][Full Text] [Related]
16. An update on the role of high-dose therapy with autologous or allogeneic stem cell transplantation in mantle cell lymphoma. Jacobsen E; Freedman A Curr Opin Oncol; 2004 Mar; 16(2):106-13. PubMed ID: 15075900 [TBL] [Abstract][Full Text] [Related]
17. In vivo purging and relapse prevention following ASCT. Gisselbrecht C Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S5-9. PubMed ID: 11840154 [TBL] [Abstract][Full Text] [Related]
18. Integrating monoclonal antibodies into the management of mantle cell lymphoma. Berinstein NL; Mangel J Semin Oncol; 2004 Feb; 31(1 Suppl 2):2-6. PubMed ID: 15042527 [TBL] [Abstract][Full Text] [Related]
19. Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma. Andersen NS; Pedersen LB; Laurell A; Elonen E; Kolstad A; Boesen AM; Pedersen LM; Lauritzsen GF; Ekanger R; Nilsson-Ehle H; Nordström M; Fredén S; Jerkeman M; Eriksson M; Väärt J; Malmer B; Geisler CH J Clin Oncol; 2009 Sep; 27(26):4365-70. PubMed ID: 19652064 [TBL] [Abstract][Full Text] [Related]
20. High incidence of neutropenia in patients treated with rituximab after autologous stem cell transplantation. Cairoli R; Grillo G; Tedeschi A; D'Avanzo G; Marenco P; Morra E Haematologica; 2004 Mar; 89(3):361-3. PubMed ID: 15020279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]